Inventor · name-matched record
THOMPSON BRADLEY G
42 granted patents·1 pending application·0 citations·filing 2023–2025
96Inventor score
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
43 records- 0196US12540327B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·4 claims
- 0296US12540326B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·2 claims
- 0395US12595484B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Apr 7, 2026·0 cites·4 claims
- 0495US12570979B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Mar 10, 2026·0 cites·4 claims
- 0595US12565657B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Mar 3, 2026·0 cites·4 claims
- 0695US12559751B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 24, 2026·0 cites·4 claims
- 0795US12559756B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 24, 2026·0 cites·4 claims
- 0895US12540322B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·4 claims
- 0995US12540328B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·2 claims
- 1095US12540329B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·2 claims
- 1195US12534733B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 27, 2026·0 cites·4 claims
- 1295US12522833B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·4 claims
- 1395US12522828B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·4 claims
- 1495US12522829B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·4 claims
- 1595US12522832B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·4 claims
- 1695US12516327B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 6, 2026·0 cites·3 claims
- 1795US12516325B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 6, 2026·0 cites·3 claims
- 1895US12516324B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 6, 2026·0 cites·4 claims
- 1994US12584134B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Mar 24, 2026·0 cites·3 claims
- 2094US12529058B2Composition for regulating production of interfering ribonucleic acidWYVEM PHARMACEUTICALS INC·Filed 2024·Granted Jan 20, 2026·0 cites·4 claims
- 2194US12516328B2Composition for regulating production of interfering ribonucleic acidWYVEM PHARMACEUTICALS INC·Filed 2024·Granted Jan 6, 2026·0 cites·3 claims
- 2293US12522831B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·3 claims
- 2392US12559754B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2023·Granted Feb 24, 2026·0 cites·2 claims
- 2492US12540324B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 3, 2026·0 cites·3 claims
- 2592US12529075B2Plasmid encoding a NGF and Fc fusion proteinWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 20, 2026·0 cites·3 claims
- 2692US12522847B2Plasmid encoding an insulin peptide and Fc fusion proteinWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 13, 2026·0 cites·3 claims
- 2789US12565655B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Mar 3, 2026·0 cites·2 claims
- 2889US12559758B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Feb 24, 2026·0 cites·2 claims
- 2989US12553051B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Feb 17, 2026·0 cites·2 claims
- 3089US12553052B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Feb 17, 2026·0 cites·2 claims
- 3188US12570983B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Mar 10, 2026·0 cites·2 claims
- 3286US12522830B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2023·Granted Jan 13, 2026·0 cites·2 claims
- 3385US12559752B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Feb 24, 2026·0 cites·2 claims
- 3483US12522835B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Jan 13, 2026·0 cites·2 claims
- 3583US12516332B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Jan 6, 2026·0 cites·2 claims
- 3682US12545917B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Feb 10, 2026·0 cites·4 claims
- 3782US12529059B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2024·Granted Jan 20, 2026·0 cites·4 claims
- 3881US12584129B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Mar 24, 2026·0 cites·2 claims
- 3981US12529061B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Jan 20, 2026·0 cites·2 claims
- 4075US12529060B2Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Jan 20, 2026·0 cites·6 claims
- 4173US2026021201A1Composition for regulating production of proteinsWYVERN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 4269US12565652B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Mar 3, 2026·0 cites·2 claims
- 4366US12553046B1Composition for regulating production of interfering ribonucleic acidWYVERN PHARMACEUTICALS INC·Filed 2025·Granted Feb 17, 2026·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when THOMPSON BRADLEY G files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →